Prosecution Insights
Last updated: April 19, 2026

Peptilogics Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18638784 GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES WENG, PEI YONG 2141 Non-Final OA Apr 18, 2024
18447414 INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Non-Final OA Aug 10, 2023
17403194 ARTIFICIAL INTELLIGENCE ENGINE FOR GENERATING CANDIDATE DRUGS USING EXPERIMENTAL VALIDATION AND PEPTIDE DRUG OPTIMIZATION ZEMAN, MARY K 1686 Final Rejection Aug 16, 2021
17339598 ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS WOITACH, JOSEPH T 1687 Non-Final OA Jun 04, 2021
17319839 GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES KRIANGCHAIVECH, KETTIP 1686 Non-Final OA May 13, 2021

Managing Peptilogics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month